[CLDX] YoY Quarter Result on 31-Mar-2017 [#Q1]

Stock
[CLDX] Celldex Therapeutics, Inc.
Announcement Date
09-May-2017
Financial Year
2017
Quarter
31-Mar-2017 [#Q1]
Profit Trend
QoQ- -6.05%
YoY- 1.19%
Quarter Report
CLDX's Result
CLDX's Financial Summary
View:
Show?
Quarter Result
31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 CAGR
Revenue 2,728 1,425 4,068 1,534 1,303 486 416 36.77%
PBT -12,625 -17,239 -118,897 -34,261 -34,673 -30,174 -29,903 -13.37%
Tax -16 5,234 -765 5,098 -2,062 -1,614 -1,586 -53.48%
NP -12,625 -17,239 -118,132 -34,261 -34,673 -30,174 -29,903 -13.37%
Tax Rate - - - - - - - -
Total Cost 15,353 18,664 122,200 35,795 35,976 30,660 30,319 -10.71%
Ratio Analysis
31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 CAGR
NP Margin -462.79 -1,209.75 -2,903.93 -2,233.44 -2,661.01 -6,208.64 -7,188.22 -36.66%
Per Share
31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 CAGR
EPS -0.73 -1.40 -12.61 -4.19 -5.27 -4.90 -5.02 -27.46%
EPS Diluted -0.73 -1.40 -12.61 -4.19 -5.27 -4.90 -5.02 -27.46%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.